TOKYO -- Major Japanese pharmaceutical companies are reducing their business in Russia, joining their global peers in pulling back as the nation's invasion of Ukraine makes it tougher to operate there.
Pharmaceuticals
Japanese drugmakers reduce Russia business in wake of Ukraine war
They join global peers in pulling back as logistics, payment systems deteriorate
Japan's Daiichi Sankyo has halted sales of some of its drugs to local distributors in Russia.
Read Next
_2048x1152.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Pharmaceuticals
